Anti-Venom Market

Anti-Venom Market - (Anti-Venom Type - Monovalent and Polyvalent; Product Type - Snake Anti-Venom, Scorpion Anti-Venom, and Spider Anti-Venom; Distribution Channel - (Hospitals, Clinics and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Anti-venom Market - Snapshot

Biotechnology and healthcare industry is experiencing a significant demand from emerging economies across the globe. The report includes extensive analysis on the historic data across the biotechnology and healthcare segment and forecast for the anti-venom market considering all possible factors impacting the growth. The main factor driving the anti-venom market is the anti-venom treatment being the only standard treatment for snake bite with no alternative treatment. Other factors that support growth of anti-venom market is high prevalence of snake bites, scorpion bites, and other animal or insect bites such as fish stings. Encroachment of forest lands for agricultural and housing purposes has enabled human to be in close proximity to poisonous insects and animals, thus increasing the demand for anti-venom which is most effective treatment for venomous bites.

anti venom market

Developing Nations in MEA and Asia Pacific to Showcase Lucrative Prospects

Continuous research and development to provide innovative drugs and treatment for animal or insect sting has boosted the development of the anti-venom market. High demand for anti-venom Asia Pacific, Middle East & Asia, and Latin America has attracted regional manufacturers for anti-venom development. Increasing demand for anti-venom in developing countries has led to presence of key players in countries like India and Africa, offering anti-venom products at affordable price. The developing global economic conditions create a huge opportunity for the expansion of the anti-venom market. The rise in individual per capita incomes is bound to increase the spending on health care. In the developing countries of Asia Pacific and Middle East, growing population and per capita income are important drivers of the market. According to economist intelligence unit (EIU), the number of high-income households are estimated to be around 540 million by 2019, out of which Asia Pacific is likely to contribute a share of more than 50%.

Region wise global anti-venom market is segmented into five key regions, namely North America (NA), Europe, Asia Pacific (APAC), Latin America (LA), and Middle East & Africa (MEA). Middle East & Africa leads the global anti-venom market followed by Asia Pacific due to presence of highly poisonous snakes in many countries like India, South Africa, Nigeria, etc., which report to have highest death rate due to snake bite. India and South Africa recorded with significant market share in the anti-venom market. India holds dominant position in Asia Pacific anti-venom market accounting to about 50% of the total annual snake bites occurring worldwide, as reported by WHO, thus attracting anti-venom manufacturers in the region.

Polyvalent Segment to Record High Growth

Based on anti-venom type, anti-venom market is segmented into monovalent and polyvalent anti-venom. While based on product type anti-venom market is segmented into snake anti-venom, scorpion anti-venom, spider anti-venom, and other anti-venoms. The market for anti-venom is majorly driven by polyvalent segment. Snake anti-venom segment holds the largest market for anti-venom, owing to high prevalence of venomous snake bites causing high rate of mortality and morbidity without anti-venom treatment. Anti-venom market is further segmented by distribution channel into four main categories i.e. hospitals, clinics, ambulatory surgical centers, and other distribution channels. Segment hospital holds largest share amongst the four in anti-venom market.

High cost of anti-venom owing to high production cost and lack in availability of essential anti-venom stock worldwide is major concern for growth of anti-venom market. Moreover the snake bite health hazard is listed amongst the top neglected tropical disease. Thus, considering this efforts have been taken on national and international level to increase production of anti-venom to gap the supply for anti-venom demand. The anti-venom market is fragmented, with presence of several large industry players. CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics, etc.

Anti-Venom Market is Gaining Significant Revenues from Agricultural Nations of Asia Pacific

Ceaseless innovative work to give imaginative medications and treatment to creature or creepy crawly sting has supported the advancement of the anti-venom market. Biotechnology and medical services industry is seeing a critical interest from creating economies all around the world. The key factor driving the development of anti-venom market is the interest for anti-venom treatment being the solitary approved treatment for snake chomp with no choice for elective treatment. Infringement of backwoods lands for horticultural and lodging purposes has empowered human to be in close in toxic creepy crawlies and creatures, hence expanding pervasiveness of venomous nibbles. High pervasiveness of scorpion chomps, snake nibbles, and other creature or bug chomps, for example, fish stings are different elements supporting development of anti-venom market.

Biotechnology and medical services industry is encountering a huge interest from arising economies across the globe. The report remembers broad investigation for the memorable information across the biotechnology and medical care portion and figure for the anti-venom market considering all potential elements affecting the development. The primary factor driving the anti-venom market is the anti-venom treatment being the solitary standard treatment for snake nibble with no elective treatment. Different elements that development of anti-venom market is high commonness of snake nibbles, scorpion chomps, and other creature or creepy crawly chomps, for example, fish stings. Infringement of woods lands for agrarian and lodging purposes has empowered human to be in nearness to toxic bugs and creatures, in this way expanding the interest for anti-venom which is best treatment for venomous chomps.

Expanding interest for anti-venom in agricultural nations has prompted presence of vital participants in nations like India and Africa, offering anti-venom items at reasonable cost. The creating worldwide financial conditions set out a gigantic freedom for the extension of the anti-venom market. The ascent in individual per capita wages will undoubtedly build the spending on medical care. In the agricultural nations of Asia Pacific and Middle East, developing populace and per capita pay are significant drivers of the market.

The anti-venom market has been segmented as follows:

by Anti-venom type

  • Monovalent
  • Polyvalent

by Product Type

  • Snake anti-venom
  • Scorpion anti-venom
  • Spider anti-venom
  • Others

by Distribution Channel

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

    Chapter 1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

    Chapter 2. Assumptions and Research Methodology

    Chapter 3. Executive Summary: Global Anti-venom Market              

    Chapter 4. Market Overview
    4.1. Introduction
           4.1.1. Anti-Venom Type Definition
           4.1.2. Industry Evolution / Developments
    4.2. Market Overview
    4.3. Market Dynamics
           4.3.1. Drivers
           4.3.2. Restraints
           4.3.3. Opportunities
           4.3.4. Trends
    4.4. Anti-venom Market Analysis and Forecast, 2016 – 2024
           4.4.1. Pricing – Actuals and Projections, 2016-2024 (US$)
           4.4.2. Market Revenue Projections (US$ Mn)
    4.5. Porter’s Five Force Analysis
    4.6. Value Chain Analysis
    4.7. Market Outlook

    Chapter 5. Global Anti-venom Market Analysis and Forecasts, By Anti-Venom Type
    5.1. Introduction & Definition
    5.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           5.2.1. Monovalent
           5.2.2. Polyvalent
    5.3. Market Attractiveness By Anti-Venom Type  
    5.4. Key Trends

    Chapter 6. Global Anti-venom Market Analysis and Forecasts, By Product Type
    6.1. Introduction & Definition
    6.2. Market Size (US$ Mn) Forecast By Product Type
           6.2.1. Snake Anti-Venom
           6.2.2. Scorpion Anti-Venom
           6.2.3. Spider Anti-Venom
           6.2.4. Others
    6.3. Market Attractiveness By Product Type  
    6.4. Key Trends

    Chapter 7. Global Anti-venom Market Analysis and Forecasts, By Distribution Channel
    7.1. Introduction & Definition
    7.2. Market Size (US$ Mn) Forecast By Distribution Channel
           7.2.1. Hospitals
           7.2.2. Clinics       
           7.2.3. Ambulatory Surgical centers
           7.2.4. Others
    7.3. Market Attractiveness By Distribution Channel
    7.4. Key Trends

    Chapter 8. Global Anti-venom Market Analysis and Forecasts, By Region
    8.1. Introduction & Definition
    8.2. Market Size (US$ Mn) Forecast By Region
           8.2.1. North America
           8.2.2. Latin America
           8.2.3. Europe
           8.2.4. Asia Pacific        
           8.2.5. Middle East and Africa
    8.3. Market Attractiveness By Region
    8.4. Key Trend

    Chapter 9. North America Anti-venom Market Analysis and Forecast
    9.1. Introduction
    9.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           9.2.1. Monovalent       
           9.2.2. Polyvalent
    9.3. Market Size (US$ Mn) Forecast By Product Type
           9.3.1. Snake Anti-Venom
           9.3.2. Scorpion Anti-Venom       
           9.3.3. Spider Anti-Venom
           9.3.4. Others
    9.4. Market Size (US$ Mn) Forecast By Distribution Channel
           9.4.1. Hospitals
           9.4.2. Clinics
           9.4.3. Ambulatory Surgical centers
           9.4.4. Others
    9.5. Market Size (US$ Mn) Forecast, By Country
           9.5.1. U.S.
           9.5.2. Canada
    9.6. Market Attractiveness Analysis 
           9.6.1. By Anti-Venom Type
           9.6.2. By Product Type
           9.6.3. By Distribution Channel
           9.6.4. By Country
    9.7. Key Trend

    Chapter 10. Europe Anti-venom Market Analysis and Forecast
    10.1. Introduction
    10.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           10.2.1. Monovalent
           10.2.2. Polyvalent
    10.3. Market Size (US$ Mn) Forecast By Product Type
           10.3.1. Snake Anti-Venom
           10.3.2. Scorpion Anti-Venom
           10.3.3. Spider Anti-Venom       
           10.3.4. Others
    10.4. Market Size (US$ Mn) Forecast By Distribution Channel       
           10.4.1. Hospitals
           10.4.2. Clinics
           10.4.3. Ambulatory Surgical centers
           10.4.4. Others
    10.5. Market Size (US$ Mn) Forecast, By Country
           10.5.1. U.K.       
           10.5.2. France
           10.5.3. Germany
           10.5.4. Spain
           10.5.5. Rest of Europe
    10.6. Market Attractiveness Analysis 
           10.6.1. By Anti-Venom Type
           10.6.2. By Product Type
           10.6.3. By Distribution Channel 
           10.6.4. By Country 
    10.7. Key Trend 

    Chapter 11. Asia Pacific Anti-venom Market Analysis and Forecast
    11.1. Introduction
    11.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           11.2.1. Monovalent
           11.2.2. Polyvalent
    11.3. Market Size (US$ Mn) Forecast By Product Type
           11.3.1. Snake Anti-Venom
           11.3.2. Scorpion Anti-Venom
           11.3.3. Spider Anti-Venom
           11.3.4. Others
    11.4. Market Size (US$ Mn) Forecast By Distribution Channel
           11.4.1. Hospitals
           11.4.2. Clinics
           11.4.3. Ambulatory Surgical centers
           11.4.4. Others
    11.5. Market Size (US$ Mn) Forecast, By Country
           11.5.1. Japan
           11.5.2. China
           11.5.3. India
           11.5.4. Rest of APAC
    11.6. Market Attractiveness Analysis 
           11.6.1. By Anti-Venom Type
           11.6.2. By Product Type
           11.6.3. By Distribution Channel
           11.6.4. By Country 
    11.7. Key Trend 

    Chapter 12. Latin America Anti-venom Market  Analysis and Forecast
    12.1. Introduction
    12.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           12.2.1. Monovalent
           12.2.2. Polyvalent
    12.3. Market Size (US$ Mn) Forecast By Product Type
           12.3.1. Snake Anti-Venom
           12.3.2. Scorpion Anti-Venom
           12.3.3. Spider Anti-Venom
           12.3.4. Others
    12.4. Market Size (US$ Mn) Forecast By Distribution Channel
           12.4.1. Hospitals
           12.4.2. Clinics
           12.4.3. Ambulatory Surgical centers
           12.4.4. Others
    12.5. Market Size (US$ Mn) Forecast, By Country
           12.5.1. Brazil
           12.5.2. Mexico
           12.5.3. Argentina
           12.5.4. Rest of Latin America
    12.6. Market Attractiveness Analysis 
           12.6.1. By Anti-Venom Type
           12.6.2. By Product Type
           12.6.3. BY Distribution Channel
           12.6.4. By Country 
    12.7. Key Trend 

    Chapter 13. Middle East & Africa Anti-venom Market  Analysis and Forecast
    13.1. Introduction
    13.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
           13.2.1. Monovalent
           13.2.2. Polyvalent
    13.3. Market Size (US$ Mn) Forecast By Product Type
           13.3.1. Snake Anti-Venom
           13.3.2. Scorpion Anti-Venom
           13.3.3. Spider Anti-Venom
           13.3.4. Others
    13.4. Market Size (US$ Mn) Forecast By Distribution Channel
           13.4.1. Hospitals
           13.4.2. Clinics
           13.4.3. Ambulatory Surgical centers
           13.4.4. Others
    13.5. Market Size (US$ Mn) Forecast, By Country
           13.5.1. South Africa
           13.5.2. Saudi Arabia
           13.5.3. Rest of MEA
    13.6. Market Attractiveness Analysis 
           13.6.1. By Anti-Venom Type
           13.6.2. By Product Type
           13.6.3. BY Distribution Channel
           13.6.4. By Country 
    13.7. Key Trend 

    Chapter 14. Competition Landscape
    14.1. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
           14.1.1. CSL Behring
                      14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.1.1.2. Product Portfolio
                      14.1.1.3. SWOT Analysis
                      14.1.1.4. Strategic Overview
           14.1.2. Bharat Serums and Vaccines Ltd
                      14.1.2.1.  Company Overview (HQ, Business Segments, Employee Strength)
                      14.1.2.2. Product Portfolio
                      14.1.2.3. SWOT Analysis
                      14.1.2.4. Strategic Overview
           14.1.3. Haffkine Bio-Pharmaceutical Corporation Ltd 
                      14.1.3.1. Company Overview 
                      14.1.3.2. Product Portfolio
                      14.1.3.3. SWOT Analysis
                      14.1.3.4. Financial Overview
                      14.1.3.5. Strategic Overview
           14.1.4. Vacsera 
                      14.1.4.1. Company Overview 
                      14.1.4.2. Product Portfolio
                      14.1.4.3. SWOT Analysis
                      14.1.4.4. Financial Overview
                      14.1.4.5. Strategic Overview
           14.1.5. Vins Bioproducts Limited
                      14.1.5.1. Company Overview 
                      14.1.5.2. Product Portfolio
                      14.1.5.3. SWOT Analysis
                      14.1.5.4. Financial Overview
                      14.1.5.5. Strategic Overview
           14.1.6. Rare Disease Therapeutics, Inc.  
                      14.1.6.1. Company Overview 
                      14.1.6.2. Product Portfolio
                      14.1.6.3. SWOT Analysis
                      14.1.6.4. Financial Overview
                      14.1.6.5. Strategic Overview
           14.1.7. Bharat Biotech
                      14.1.7.1. Company Overview 
                      14.1.7.2. Product Portfolio
                      14.1.7.3. SWOT Analysis
                      14.1.7.4. Financial Overview
                      14.1.7.5. Strategic Overview
           14.1.8. BTG International Ltd.
                      14.1.8.1. Company Overview 
                      14.1.8.2. Product Portfolio
                      14.1.8.3. SWOT Analysis
                      14.1.8.4. Financial Overview
                      14.1.8.5. Strategic Overview

    Chapter 15. Key Takeaways

    List of Tables

    Table 01: Global Anti-venom Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 02: Global Anti-venom Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 03: Global Anti-venom Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 04: Global Anti-venom Market Size (US$ Mn) Forecast, by Region,
    Table 05: Asia Pacific Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 06: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 07: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 08: Asia Pacific Anti-venom Market Size (US$ Mn) Forecast, by Country,
    Table 09: Middle East & Africa Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 10: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 11: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 12: Middle East & Africa Anti-venom Market Size (US$ Mn) Forecast, by Country,
    Table 13: Latin America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 14: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 15: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 16: Latin America Anti-venom Market Size (US$ Mn) Forecast, by Country,
    Table 17: North America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 18: North America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 19: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 20: North America Anti-venom Market Size (US$ Mn) Forecast, by Country,
    Table 21: Europe Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
    Table 22: Europe Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 24: Europe Anti-venom Market Size (US$ Mn) Forecast, by Country,

    List of Figures

    Figure 01: Global Anti-venom Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 02: Global Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 03: Global Monovalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 04: Global Polyvalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 05: Global Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 06: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025 
    Figure 07: Global Snake Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 08: Global Scorpion Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 09: Global Spider Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 10: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 11: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 13: Global Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 14: Global Hospitals Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 15: Global Clinics Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 16: Global Ambulatory Surgical Centers Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 17: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 18: Global Anti-Venom Market Attractiveness Analysis, by Distribution Channel
    Figure 19: Global Anti-Venom Market Value Share Analysis, by Region, 2017 and 2025 
    Figure 20: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 21: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 22: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 23: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 24: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 25: Global Anti-Venom Market Attractiveness Analysis, by Region
    Figure 26: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 27: Asia Pacific Anti-Venom Market Attractiveness Analysis, by Country
    Figure 28: Asia Pacific Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 29: Asia Pacific Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 30: Asia Pacific Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 31: Asia Pacific Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
    Figure 32: Asia Pacific Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 33: Asia Pacific Anti-venom Market Attractiveness Analysis, by Product Type
    Figure 34: Asia Pacific Anti-venom Market Attractiveness Analysis, by Distribution Channel
    Figure 35: Asia Pacific Anti-venom Market Attractiveness Analysis, by Country
    Figure 36: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 37: Middle East & Africa Anti-Venom Market Attractiveness Analysis, by Country
    Figure 38: Middle East & Africa Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 39: Middle East & Africa Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 40: Middle East & Africa Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 41: Middle East & Africa Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
    Figure 42: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 43: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Product Type
    Figure 44: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Distribution Channel
    Figure 45: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Country
    Figure 46: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 47: Latin America Anti-Venom Market Attractiveness Analysis, by Country
    Figure 48: Latin America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 49: Latin America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 50: Latin America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 51: Latin America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
    Figure 52: Latin America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 53: Latin America Anti-venom Market Attractiveness Analysis, by Product Type
    Figure 54: Latin America Anti-venom Market Attractiveness Analysis, by Distribution Channel
    Figure 55: Latin America Anti-venom Market Attractiveness Analysis, by Country
    Figure 56: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 57: North America Anti-Venom Market Attractiveness Analysis, by Country
    Figure 58: North America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 59: North America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 60: North America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 61: North America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
    Figure 62: North America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 63: North America Anti-venom Market Attractiveness Analysis, by Product Type
    Figure 64: North America Anti-venom Market Attractiveness Analysis, by Distribution Channel
    Figure 65: North America Anti-venom Market Attractiveness Analysis, by Country
    Figure 66: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 67: Europe Anti-Venom Market Attractiveness Analysis, by Country
    Figure 68: Europe Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
    Figure 69: Europe Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
    Figure 70: Europe Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
    Figure 71: Europe Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
    Figure 72: Europe Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
    Figure 73: Europe Anti-venom Market Attractiveness Analysis, by Product Type
    Figure 74: Europe Anti-venom Market Attractiveness Analysis, by Distribution Channel
    Figure 75: Europe Anti-venom Market Attractiveness Analysis, by Country
    Figure 76: Breakdown of Net Sales (2015), by Segments: CSL Behring
    Figure 77: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: CSL Behring
    Figure 78: Breakdown of Net Sales (2015), by Segments: Bharat Serums and Vaccines Ltd
    Figure 79: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Serums and Vaccines Ltd
    Figure 80: Breakdown of Net Sales (2015), by Segments: Haffkine Bio-Pharmaceutical Corporation Ltd
    Figure 81: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Haffkine Bio-Pharmaceutical Corporation Ltd
    Figure 82: Breakdown of Net Sales (2015), by Segments: Vacsera
    Figure 83: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vacsera
    Figure 84: Breakdown of Net Sales (2015), by Segments: Vins Bioproducts Limited
    Figure 85: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vins Bioproducts Limited
    Figure 86: Breakdown of Net Sales (2015), by Segments: Rare Disease Therapeutics, Inc.  
    Figure 87: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Rare Disease Therapeutics, Inc.  
    Figure 88: Breakdown of Net Sales (2015), by Segments: Bharat Biotech 
    Figure 89: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Biotech
    Figure 90: Breakdown of Net Sales (2015), by Segments: BTG International Ltd.
    Figure 91: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: BTG International Ltd.

     

Copyright © Transparency Market Research, Inc. All Rights reserved